je.st
news
Biz Break: Gilead hepatitis C drugs rack up more huge sales, cash headed to investors
2015-02-04 02:13:49| Biotech - Topix.net
Today: Gilead Sciences completes a transformational financial year with another huge quarter, thanks to sales of Foster City company's breakthrough hepatitis C medications, and will push that cash back to investors as discounts begin to take effect. Also: Twitter jumps amid changes.
Tags: to
sales
break
cash
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||